Concepedia

Konstantin Articus

KA

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2011

Affiliations

Novartis (Germany)(Current)

Philipps University of Marburg

University Hospital Magdeburg

Sorbian Institute

Konstantin Articus is an author at Novartis (Germany) specializing in menopause, women's health, and bone health.

Top concepts

Publications per year

2011–2023

5

Publications

5

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions

Georg Adler, B. Mueller, Konstantin Articus · International Journal of Clinical Practice · 2014 · 44 citations · Full text

Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass

Peyman Hadji, D. Gamerdinger, Willy Spieler et al. · Osteoporosis International · 2011 · 27 citations

, , +12

A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer’s disease

Konstantin Articus, Monika Baier, Ferenc Tracik et al. · International Journal of Clinical Practice · 2011 · 25 citations

Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass

Peyman Hadji, Volker Ziller, D. Gamerdinger et al. · Osteoporosis International · 2011 · 23 citations

, , +8

Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease

Wolfgang H. Oertel, Hans‐Helge Müller, Marcus M. Unger et al. · NEJM Evidence · 2023 · 23 citations

1–5 of 5